Developer

Country

Clinical Trial Phase

Strategy

CanSino Biological Inc./Beijing Institute of Biotechnology

China

I and II

Non-replicating viral vector

Beijing Institute of Biological Products/ Wuhan Institute of Biological Products

China

I

Inactivated virus

Sinovac

China

I

Inactivated virus

University of Oxford

UK

I

Non-Replicating Viral Vector

BioNTech/Fosun Pharma/Pfizer

USA

I

RNA

Moderna/NIAID

USA

I

RNA

Inovio Pharmaceutical

USA

I

DNA